These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine. Bode BW Endocr Pract; 2011; 17(2):271-80. PubMed ID: 21134878 [TBL] [Abstract][Full Text] [Related]
5. Effects of phenol and meta-cresol depletion on insulin analog stability at physiological temperature. Teska BM; Alarcón J; Pettis RJ; Randolph TW; Carpenter JF J Pharm Sci; 2014 Aug; 103(8):2255-67. PubMed ID: 24909933 [TBL] [Abstract][Full Text] [Related]
6. Stability of U-10 and U-50 dilutions of insulin lispro. Stickelmeyer MP; Graf CJ; Frank BH; Ballard RL; Storms SM Diabetes Technol Ther; 2000; 2(1):61-6. PubMed ID: 11467323 [TBL] [Abstract][Full Text] [Related]
7. Comparison of in vitro stability for insulin aspart and insulin glulisine during simulated use in insulin pumps. Senstius J; Poulsen C; Hvass A Diabetes Technol Ther; 2007 Dec; 9(6):517-21. PubMed ID: 18034606 [TBL] [Abstract][Full Text] [Related]
8. In vitro stability of insulin aspart in simulated continuous subcutaneous insulin infusion using a MiniMed 508 insulin pump. Senstius J; Harboe E; Westermann H Diabetes Technol Ther; 2007 Feb; 9(1):75-9. PubMed ID: 17316101 [TBL] [Abstract][Full Text] [Related]
9. In vitro Stability of Biosimilar Insulin Aspart SAR341402 in the Medtronic MiniMed Insulin Pumps. Mohnicke M; Blecher A; Beichert K; Bidlingmaier B; Todt EJ; Dette C; Rotthaeuser B; Mukherjee B J Pharm Sci; 2023 Apr; 112(4):963-973. PubMed ID: 36521561 [TBL] [Abstract][Full Text] [Related]
10. Stability and performance of rapid-acting insulin analogs used for continuous subcutaneous insulin infusion: a systematic review. Kerr D; Wizemann E; Senstius J; Zacho M; Ampudia-Blasco FJ J Diabetes Sci Technol; 2013 Nov; 7(6):1595-606. PubMed ID: 24351186 [TBL] [Abstract][Full Text] [Related]
11. Better postprandial glucose stability during continuous subcutaneous infusion with insulin aspart compared with insulin lispro in patients with type 1 diabetes. Bartolo PD; Pellicano F; Scaramuzza A; Sardu C; Casetti T; Bosi E; Miselli V; Brandolini S; Fabbri T; Meandri P; Cannatà F Diabetes Technol Ther; 2008 Dec; 10(6):495-8. PubMed ID: 19049379 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of insulin glulisine to insulin aspart on breakfast postprandial blood glucose levels in children with type 1 diabetes mellitus on multiple daily injections. Cemeroglu AP; Kleis L; Wood A; Parkes C; Wood MA; Davis AT Endocr Pract; 2013; 19(4):614-9. PubMed ID: 23425652 [TBL] [Abstract][Full Text] [Related]
13. Influence of local skin temperature and choice of insulin analog on catheter occlusion rates during continuous insulin infusion: an exploratory study. Naik S; Kerr D; Begley J; Morton J Diabetes Technol Ther; 2012 Nov; 14(11):1018-22. PubMed ID: 23101952 [TBL] [Abstract][Full Text] [Related]
15. Use of rapid-acting insulin analogues in the treatment of patients with type 1 and type 2 diabetes mellitus: insulin pump therapy versus multiple daily injections. Bode BW Clin Ther; 2007; 29 Suppl D():S135-44. PubMed ID: 18191065 [TBL] [Abstract][Full Text] [Related]
16. Glycemic control after 6 days of insulin pump reservoir use in type 1 diabetes: results of double-blind and open-label cross-over trials of insulin lispro and insulin aspart. Tamborlane WV; Renard E; Wadwa RP; Blevins T; Jacober SJ; Liu R; D'Souza DN; Rees TM J Diabetes; 2015 Mar; 7(2):270-8. PubMed ID: 24734891 [TBL] [Abstract][Full Text] [Related]
17. 14-day in vitro chemical stability of insulin lispro in the MiniMed Paradigm pump. Sharrow SD; Glass LC; Dobbins MA Diabetes Technol Ther; 2012 Mar; 14(3):264-70. PubMed ID: 22107252 [TBL] [Abstract][Full Text] [Related]
18. Investigation of Pump Compatibility of Fast-Acting Insulin Aspart in Subjects With Type 1 Diabetes. Zijlstra E; Demissie M; Graungaard T; Heise T; Nosek L; Bode B J Diabetes Sci Technol; 2018 Jan; 12(1):145-151. PubMed ID: 28918652 [TBL] [Abstract][Full Text] [Related]
19. Use of a novel double-antibody technique to describe the pharmacokinetics of rapid-acting insulin analogs. Lindström T; Hedman CA; Arnqvist HJ Diabetes Care; 2002 Jun; 25(6):1049-54. PubMed ID: 12032113 [TBL] [Abstract][Full Text] [Related]
20. Concentration and Chemical Stability of Commercially Available Insulins: A High-Resolution Mass Spectrometry Study. Baechler F; Stettler C; Vogt B; Bally L; Groessl M Diabetes Technol Ther; 2020 Apr; 22(4):326-329. PubMed ID: 32031881 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]